Boehringer Ingelheim

Diabetes meds from AZ, J&J and Lilly sharply cut death rates in real-world analysis
Fierce Pharma
Mon, 03/20/17 - 10:57 am
AstraZeneca
JNJ
Eli Lilly
Boehringer Ingelheim
diabetes
Farixga
Invokana
Jardiance
SGLT2 inhibitor
Merck and Pfizer prep for battle with SGLT2, combo diabetes filings
Fierce Pharma
Mon, 03/13/17 - 10:18 am
Merck
Pfizer
SGLT2 inhibitor
diabetes
ertugliflozin
Jardiance
Boehringer Ingelheim
Eli Lilly
JNJ
Invokana
AstraZeneca
Farxiga
Boehringer Ingelheim's Humira Biosimilar Under Review by EMA, FDA
Yahoo/GuruFocus
Fri, 01/20/17 - 09:45 am
Boehringer Ingelheim
Humira
biosimilars
FDA
EMA
BI 695501
AbbVie
Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017
Yahoo
Mon, 01/2/17 - 12:09 pm
Sanofi
Boehringer Ingelheim
consumer health
animal health
Merial
ADA guidelines highlight new Jardiance label
BioPharma Dive
Mon, 12/19/16 - 11:39 am
ADA
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
Novo Nordisk
Victoza
Lilly, Boehringer’s Basaglar long-acting insulin now available in the U.S.
Mass Device
Thu, 12/15/16 - 06:41 pm
Eli Lilly
Boehringer Ingelheim
Basaglar
insulin
diabetes
long-acting insulin
Bayer helps Boehringer Ingelheim advance $25.5B asset swap for Merial
Bizjournals.com
Thu, 12/8/16 - 10:58 am
Bayer
Boehringer Ingelheim
Merial
animal health
Vetmedica
BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists
Medical Marketing and Media
Tue, 12/6/16 - 10:05 pm
Boehringer Ingelheim
Eli Lilly
cardiologists
diabetes
Jardiance
Boehringer whacks more jobs in U.S.
Fierce Pharma
Fri, 12/2/16 - 10:43 am
Boehringer Ingelheim
layoffs
drug reps
R&D
Boehringer moves the farm to Georgia
BioPharma Dive
Thu, 11/17/16 - 04:45 pm
Boehringer Ingelheim
Vetmedica
animal health
Georgia
Fate of Lilly's Jardiance franchise rests on FDA's delayed heart-benefits indication
Fierce Pharma
Tue, 11/1/16 - 10:13 am
Eli Lilly
Jardiance
FDA
diabetes
Boehringer Ingelheim
Boehringer flags PhIII success for another Humira knockoff, setting up a crowded field of cheaper rivals — eventually
Endpoints
Wed, 10/26/16 - 09:16 pm
Boehringer Ingelheim
Humira
BI 695501
AbbVie
rheumatoid arthritis
Sunovion hires former BI exec as VP of marketing
Medical Marketing and Media
Tue, 10/25/16 - 03:50 pm
Sunovion
Boehringer Ingelheim
marketing
BI tapping real-world data for Pradaxa
BioPharma Dive
Mon, 10/24/16 - 11:45 pm
Boehringer Ingelheim
Pradaxa
non-valvular atrial fibrillation
Deaths, accusations of insider trading and an early warning from Boehringer stir Hanmi controversy
Endpoints
Tue, 10/11/16 - 09:24 pm
insider trading
Hanmi Pharma
Boehringer Ingelheim
Korea
Boehringer Beats A Brave Route With Oncolytic Virus Deal
Seeking Alpha
Fri, 10/7/16 - 09:03 am
Boehringer Ingelheim
VSV-GP
ViraTherapeutics
Lilly to buy Boehringer's U.S. pet vaccines unit
Yahoo/Reuters
Wed, 10/5/16 - 09:41 am
Eli Lilly
Boehringer Ingelheim
Elanco
animal health
M&A
vaccines
2 patients dead, Boehringer scraps plans for high-speed development, kills $730M Hanmi deal
Endpoints
Fri, 09/30/16 - 10:34 am
Boehringer Ingelheim
drug development
Hanmi Pharma
Korea
Which drugmakers have the healthiest presence on social media?
Medical Marketing and Media
Wed, 09/28/16 - 10:40 am
social media
Eli Lilly
JNJ
Boehringer Ingelheim
Novo Nordisk
Analyzing Sanofi’s Asset Swap Deal with Boehringer Ingelheim
Market Realist
Thu, 09/8/16 - 06:29 pm
Sanofi
Boehringer Ingelheim
animal health
M&A
Merial
consumer health

Pages